The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Figure 1.4
Figure 1.4
Trends in SEER Incidence and US Death Rates by Primary Cancer Site, 2008-2017
Trends in SEER Incidence
| Cancer Site | Annual Percent Change, 2008-2017 |
|---|---|
| Liver & Intrahepatic Bile Duct | 1.4 * |
| Melanoma of the Skin | 1.2 * |
| Thyroid | 1.0 |
| Corpus & Uterus, NOS | 1.0 * |
| Myeloma | 0.7 * |
| Oral Cavity & Pharynx | 0.5 * |
| Pancreas | 0.5 * |
| Testis | 0.5 * |
| Kidney & Renal Pelvis | 0.4 * |
| Breast (Female) | 0.2 |
| Leukemia | -0.3 |
| Cervix Uteri | -0.7 |
| Stomach | -0.8 * |
| Brain & Other Nervous System | -0.8 * |
| Non-Hodgkin Lymphoma | -0.8 * |
| All Sites Except Lung & Bronchus | -0.9 * |
| All Cancer Sites | -1.1 * |
| Urinary Bladder | -1.4 * |
| Esophagus | -1.5 * |
| Lung & Bronchus (Female) | -1.5 * |
| Hodgkin Lymphoma | -1.6 * |
| Ovary a | -2.1 * |
| Colon & Rectum | -2.3 * |
| Lung & Bronchus (Male) | -2.9 * |
| Larynx | -3.0 * |
| Prostate | -4.5 * |
Trends in US Mortality
| Cancer Site | Annual Percent Change, 2008-2017 |
|---|---|
| Corpus & Uterus, NOS | 2.1 * |
| Liver & Intrahepatic Bile Duct | 2.0 * |
| Oral Cavity & Pharynx | 0.6 * |
| Brain & Other Nervous System | 0.5 * |
| Testis | 0.4 |
| Pancreas | 0.2 |
| Thyroid | -0.2 |
| Urinary Bladder | -0.3 * |
| Myeloma | -0.4 |
| Cervix Uteri | -0.4 * |
| All Sites Except Lung & Bronchus | -1.0 * |
| Esophagus | -1.1 * |
| Kidney & Renal Pelvis | -1.2 * |
| Breast (Female) | -1.4 * |
| All Cancer Sites | -1.6 * |
| Leukemia | -1.6 * |
| Stomach | -2.0 * |
| Colon & Rectum | -2.1 * |
| Larynx | -2.2 * |
| Non-Hodgkin Lymphoma | -2.2 * |
| Prostate | -2.2 * |
| Ovary | -2.2 * |
| Lung & Bronchus (Female) | -2.6 * |
| Melanoma of the Skin | -2.8 * |
| Lung & Bronchus (Male) | -3.8 * |
| Hodgkin Lymphoma | -4.2 * |
Footnotes:
Source: SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey Georgia excluding ATL/RG, Idaho, New York and Massachusetts) and US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention.
Underlying rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103).
For sex-specific cancer sites, the population was limited to the population of the appropriate sex.
* The APC is significantly different from zero (p<.05).
a Ovary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.